Timing of inhibitor development in more than 1000 previously untreated patients with severe hemophilia A

Affiliations

• ¹ PedNet Haemophilia Research Foundation, Baarn, The Netherlands.
• ² Van Creveld Kliniek, University Medical Center Utrecht, Utrecht, The Netherlands.
• ³ Division of Haematology/Oncology, Hospital for Sick Children, Toronto, ON, Canada.
• ⁴ Centre de Recherche en Cardiovasculaire et Nutrition (C2VN), Aix Marseille University, Institut National de la Recherche Agronomique (INRA), INSERM, Marseille, France.
• ⁵ Centre for Bleeding Disorders, La Timone Children Hospital, Assistance Publique-Hopitaux de Marseille (APHM), Marseille, France.
• ⁶ National Hemophilia Center, Ministry of Health, Sheba Medical Center, Tel Hashomer, Israel.
• ⁷ Dr V. Haunersches Kinderspital, University of Munich, Munich, Germany.
• ⁸ Clinical and Molecular Hemostasis, Department of Pediatrics and Adolescent Medicine, J .W. Goethe University Hospital, Frankfurt, Germany.
• ⁹ Department of Paediatrics, Medical University Hospital of Vienna, Vienna, Austria.
• ¹⁰ Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy; and.
• ¹¹ Department of Clinical Sciences and.
• ¹² Department of Pediatrics, Malmö-Lund University, Lund, Sweden.